Delphi Management Partners VIII, L.L.C. 13F Holdings · last filed Q3 2021
Delphi Management Partners VIII, L.L.C. reported 4 securities worth $138.46M in its SEC 13F filing for Q3 2021 (period ended 2021-09-30). Top holdings: TNDM (86.22%), KPTI (9.51%), CALA (3.82%).
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | TNDM | Tandem Diabetes, Inc. | $119.4M | 86.22% | 1.0M | Hold |
| 2 | KPTI | Karyopharm Therapeutics, Inc. | $13.2M | 9.51% | 2.3M | Hold |
| 3 | CALA | Calithera Biosciences, Inc. | $5.3M | 3.82% | 2.4M | Hold |
| 4 | MREO | Mereo BioPharma Group PLC | $621,000 | 0.45% | 256,734 | Hold |
Source: SEC Form 13F filings · as of 2021-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR